Midwest Trust’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Midwest Trust's DGX Position: Q2 2026 in Review
Midwest Trust reduced its Quest Diagnostics (DGX) stake by 0.32% in Q2 2026, selling an estimated $59.7K and leaving 94,896 shares worth $20.1M. The position accounts for 0.23% of the portfolio, ranked #106.
Midwest Trust first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Midwest Trust held 94,896 shares of Quest Diagnostics worth $20.1M as of Q2 2026.
- Midwest Trust sold 304 Quest Diagnostics shares in Q2 2026, an estimated $59.7K.
- Quest Diagnostics made up 0.23% of Midwest Trust's portfolio in Q2 2026, its #106 holding.
- Midwest Trust first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
- 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.